Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

208 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
GATA 2 Deficiency: Focus on Immune System Impairment.
Fabozzi F, Mastronuzzi A, Ceglie G, Masetti R, Leardini D. Fabozzi F, et al. Among authors: mastronuzzi a. Front Immunol. 2022 Jun 13;13:865773. doi: 10.3389/fimmu.2022.865773. eCollection 2022. Front Immunol. 2022. PMID: 35769478 Free PMC article. Review.
Infants with acute myeloid leukemia treated according to the Associazione Italiana di Ematologia e Oncologia Pediatrica 2002/01 protocol have an outcome comparable to that of older children.
Masetti R, Rondelli R, Fagioli F, Mastronuzzi A, Pierani P, Togni M, Menna G, Pigazzi M, Putti MC, Basso G, Pession A, Locatelli F. Masetti R, et al. Among authors: mastronuzzi a. Haematologica. 2014 Aug;99(8):e127-9. doi: 10.3324/haematol.2014.106526. Epub 2014 May 16. Haematologica. 2014. PMID: 24837468 Free PMC article. No abstract available.
Indoleamine 2,3-dioxygenase 1 (IDO1) activity in leukemia blasts correlates with poor outcome in childhood acute myeloid leukemia.
Folgiero V, Goffredo BM, Filippini P, Masetti R, Bonanno G, Caruso R, Bertaina V, Mastronuzzi A, Gaspari S, Zecca M, Torelli GF, Testi AM, Pession A, Locatelli F, Rutella S. Folgiero V, et al. Among authors: mastronuzzi a. Oncotarget. 2014 Apr 30;5(8):2052-64. doi: 10.18632/oncotarget.1504. Oncotarget. 2014. PMID: 24903009 Free PMC article.
BRAF V600E Inhibitor (Vemurafenib) for BRAF V600E Mutated Low Grade Gliomas.
Del Bufalo F, Ceglie G, Cacchione A, Alessi I, Colafati GS, Carai A, Diomedi-Camassei F, De Billy E, Agolini E, Mastronuzzi A, Locatelli F. Del Bufalo F, et al. Among authors: mastronuzzi a. Front Oncol. 2018 Nov 14;8:526. doi: 10.3389/fonc.2018.00526. eCollection 2018. Front Oncol. 2018. PMID: 30488019 Free PMC article.
Vemurafenib Treatment of Pleomorphic Xanthoastrocytoma in a Child With Down Syndrome.
Petruzzellis G, Valentini D, Del Bufalo F, Ceglie G, Carai A, Colafati GS, Agolini E, Diomedi-Camassei F, Corsetti T, Alessi I, Mastronuzzi A, Locatelli F, Cacchione A. Petruzzellis G, et al. Among authors: mastronuzzi a. Front Oncol. 2019 Apr 12;9:277. doi: 10.3389/fonc.2019.00277. eCollection 2019. Front Oncol. 2019. PMID: 31032231 Free PMC article.
Cancer Predisposition Syndromes Associated With Pediatric High-Grade Gliomas.
Ceglie G, Del Baldo G, Agolini E, Rinelli M, Cacchione A, Del Bufalo F, Vinci M, Carta R, Boccuto L, Miele E, Mastronuzzi A, Locatelli F, Carai A. Ceglie G, et al. Among authors: mastronuzzi a. Front Pediatr. 2020 Nov 12;8:561487. doi: 10.3389/fped.2020.561487. eCollection 2020. Front Pediatr. 2020. PMID: 33282797 Free PMC article. Review.
208 results